More Bioxyne Limited news
Bioxyne LimitedASX: BXN

Appendix 4C - December Quarterly

Feb 11, 2016 at 1:19 AM EST · Issued by Bioxyne Limited

Filed with ASX · Feb 11, 2016 at 1:19 AM EST

On 6ix: 6ix.com/news/appendix-4c-december-quarterly

Bioxyne Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Bioxyne Limited on 6ix

Story so far

  • December 2013 Quarterly update and Appendix 4CFeb 11, 2014
  • Appendix 4C - September QuarterlyOct 31, 2013
  • Confirmation of Release - BXN - Appendix 4C - quarterly - 31 March 2013Apr 30, 2013

Earlier from Bioxyne

  • Mariposa Health Inc. Investment UpdateFeb 10, 2016
  • Bioxyne: Amended Appendix 3Y’s for Adjustment to Directors Share InterestsFeb 11, 2014
  • December 2013 Quarterly update and Appendix 4CFeb 11, 2014
  • Expiry of Unquoted OptionsDec 4, 2013
  • Sale of HI-164OV Hunter Immunology Pty LtdDec 2, 2013

Later from Bioxyne

  • Appendix 4D - Half Yearly Report and AccountsFeb 26, 2016
  • Update On Commercialisation ProcessMar 30, 2016
  • Appendix 4C - March quarterlyApr 25, 2016
  • Bioxyne Commences New Clinical TrialJun 23, 2016
  • Appendix 4C - June QuarterlyJul 28, 2016
All Bioxyne news releases↗

Follow Bioxyne into a list and get an email when it puts out news.

Follow Bioxyne
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer